PepGen Inc.(NASDAQ:PEPG) 
PepGen Inc., a clinical-stage biotechnology company, is focused on the development of oligonucleotide therapeutics for use in the treatment of serious neurological and neuromuscular diseases. The company is headquartered in Cambridge, Massachusetts.
Website: https://pepgen.com/
Founded: 2018
IPO Price: $12 (May 06, 2022)
Sector: TECHNOLOGY
Industry: GENERAL
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.14
H 1.16
L 1.04
C 1.09
V 427,556
10EMA 1.09
20EMA 1.09
60EMA 1.09
120EMA 1.09
250EMA 1.09